
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL_R | 2,332 | 100.0% | 2.03 | 9,516 | 100.0% |
| upstream partner | # | NT | conns HRN_VP1l | % In | CV |
|---|---|---|---|---|---|
| HRN_VP1l (R) | 7 | ACh | 65.3 | 21.9% | 0.1 |
| lLN2F_a (R) | 2 | Unk | 60.6 | 20.3% | 0.1 |
| lLN2F_b (R) | 2 | GABA | 49 | 16.4% | 0.0 |
| lLN2X12 (R) | 5 | ACh | 24 | 8.1% | 0.5 |
| lLN2X11 (R) | 2 | 5-HT | 23.3 | 7.8% | 0.0 |
| lLN2X07 (R) | 2 | ACh | 17.3 | 5.8% | 0.2 |
| lLN2X06 (R) | 2 | ACh | 12.3 | 4.1% | 0.2 |
| lLN2X05 (R) | 2 | 5-HT | 9 | 3.0% | 0.3 |
| lLN2P_b (R) | 4 | Unk | 8.1 | 2.7% | 0.4 |
| lLN1_bc (R) | 15 | Unk | 6.9 | 2.3% | 0.7 |
| lLN2X10 (R) | 2 | ACh | 6.7 | 2.3% | 0.1 |
| CB1686 (R) | 3 | Unk | 2.9 | 1.0% | 0.4 |
| lLN2X03 (R) | 3 | 5-HT | 2.4 | 0.8% | 0.1 |
| OA-VUMa2 (M) | 2 | OA | 2 | 0.7% | 0.1 |
| lLN2X04 (R) | 2 | Unk | 0.9 | 0.3% | 0.0 |
| TRN_VP3a (R) | 1 | Unk | 0.7 | 0.2% | 0.0 |
| lLN1_a (R) | 1 | 5-HT | 0.7 | 0.2% | 0.0 |
| TRN_VP3b (R) | 1 | ACh | 0.7 | 0.2% | 0.0 |
| lLN2T_b (R) | 2 | Unk | 0.6 | 0.2% | 0.5 |
| CB3417 (R) | 1 | Glu | 0.4 | 0.1% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 0.4 | 0.1% | 0.0 |
| lLN2P_c (R) | 3 | GABA | 0.4 | 0.1% | 0.0 |
| ORN_V (R) | 2 | Unk | 0.4 | 0.1% | 0.3 |
| ALIN2 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| ALIN5 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| lLN2T_c (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| lLN2X09 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN41b (L) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| CB1473 (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| VP3+_l2PN (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| HRN_VP1d (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB3202 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| VP1l+_lvPN (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN41a (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.1 | 0.0% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| AL-MBDL1 (L) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_VM6v (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN49 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns HRN_VP1l | % Out | CV |
|---|---|---|---|---|---|
| HRN_VP1l (R) | 7 | ACh | 65.3 | 12.0% | 0.1 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 55 | 10.2% | 0.0 |
| lLN2F_a (R) | 2 | Unk | 47.1 | 8.7% | 0.0 |
| VP1l+_lvPN (R) | 4 | ACh | 46.9 | 8.6% | 0.1 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 43.9 | 8.1% | 0.0 |
| lLN2F_b (R) | 2 | GABA | 34.6 | 6.4% | 0.1 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 26.7 | 4.9% | 0.0 |
| lLN2X11 (R) | 2 | 5-HT | 26.3 | 4.9% | 0.2 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 25 | 4.6% | 0.0 |
| lLN2X12 (R) | 5 | Unk | 24.6 | 4.5% | 0.2 |
| CB1545 (R) | 3 | Glu | 13.9 | 2.6% | 0.6 |
| lLN2X07 (R) | 2 | ACh | 12.6 | 2.3% | 0.2 |
| VP3+_l2PN (R) | 2 | ACh | 11.4 | 2.1% | 0.1 |
| lLN2P_b (R) | 5 | Unk | 9.1 | 1.7% | 0.6 |
| lLN1_bc (R) | 16 | Unk | 8.7 | 1.6% | 0.8 |
| lLN2X10 (R) | 2 | ACh | 8.3 | 1.5% | 0.3 |
| lLN2X03 (R) | 3 | 5-HT | 7.7 | 1.4% | 0.3 |
| v2LN49 (R) | 2 | Glu | 7.6 | 1.4% | 0.1 |
| CB3417 (R) | 4 | Glu | 6.7 | 1.2% | 0.4 |
| lLN2T_b (R) | 2 | Unk | 6.4 | 1.2% | 0.1 |
| lLN2X05 (R) | 2 | 5-HT | 6.1 | 1.1% | 0.4 |
| lLN2X06 (R) | 2 | ACh | 5.6 | 1.0% | 0.4 |
| CB2571 (R) | 2 | Glu | 4.1 | 0.8% | 0.1 |
| v2LN4 (R) | 2 | ACh | 3.7 | 0.7% | 0.8 |
| lLN2P_a (R) | 3 | Unk | 3.7 | 0.7% | 0.3 |
| lLN2X04 (R) | 2 | Unk | 2.6 | 0.5% | 0.4 |
| CB3326 (R) | 2 | Glu | 2.6 | 0.5% | 0.1 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 2.4 | 0.4% | 0.0 |
| v2LN41b (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| M_lvPNm25 (R) | 1 | ACh | 1.9 | 0.3% | 0.0 |
| CSD (L) | 1 | 5-HT | 1.6 | 0.3% | 0.0 |
| CB1048 (R) | 2 | Glu | 1.3 | 0.2% | 0.6 |
| TRN_VP3b (R) | 1 | ACh | 1.1 | 0.2% | 0.0 |
| OA-VUMa5 (M) | 2 | OA | 1.1 | 0.2% | 0.5 |
| vLN24 (R) | 1 | ACh | 0.9 | 0.2% | 0.0 |
| v2LN42a (R) | 1 | Glu | 0.9 | 0.2% | 0.0 |
| lLN2T_c (R) | 2 | 5-HT | 0.9 | 0.2% | 0.3 |
| AN_multi_18 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| VP3+_vPN (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| lLN2T_e (R) | 1 | 5-HT | 0.7 | 0.1% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 0.6 | 0.1% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 0.6 | 0.1% | 0.0 |
| CB3575 (R) | 1 | Unk | 0.6 | 0.1% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.6 | 0.1% | 0.0 |
| lLN2X09 (R) | 1 | ACh | 0.6 | 0.1% | 0.0 |
| lLN2P_c (R) | 2 | GABA | 0.6 | 0.1% | 0.0 |
| M_lvPNm35 (R) | 1 | ACh | 0.4 | 0.1% | 0.0 |
| v2LN41a (R) | 1 | Unk | 0.4 | 0.1% | 0.0 |
| M_vPNml60 (R) | 2 | GABA | 0.4 | 0.1% | 0.3 |
| M_ilPNm90,M_ilPN8t91 (L) | 1 | ACh | 0.4 | 0.1% | 0.0 |
| TRN_VP3a (R) | 2 | Unk | 0.4 | 0.1% | 0.3 |
| HRN_VP1d (R) | 3 | ACh | 0.4 | 0.1% | 0.0 |
| ALIN2 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| lLN1_a (R) | 1 | 5-HT | 0.3 | 0.1% | 0.0 |
| CB1013 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| M_lvPNm24 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CB4219 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| VP5+Z_adPN (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN31 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| VP1m+_lvPN (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN42c (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| v2LN39a (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| VP3+_l2PN (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| l2LN20 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| CB1686 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.1 | 0.0% | 0.0 |
| vLN25 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| M_l2PNm14 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB3206 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB3007 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| M_lPNm11A (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_V (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |